Ossiam’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.96M Sell
15,160
-22,234
-59% -$11.7M 0.09% 142
2025
Q1
$23.7M Buy
37,394
+21,221
+131% +$13.5M 0.33% 55
2024
Q4
$11.5M Sell
16,173
-997
-6% -$710K 0.2% 80
2024
Q3
$18M Sell
17,170
-752
-4% -$791K 0.35% 59
2024
Q2
$18.8M Buy
17,922
+12,493
+230% +$13.1M 0.36% 62
2024
Q1
$5.23M Buy
5,429
+302
+6% +$291K 0.09% 138
2023
Q4
$4.5M Buy
5,127
+1,322
+35% +$1.16M 0.07% 128
2023
Q3
$3.13M Sell
3,805
-37,071
-91% -$30.5M 0.06% 154
2023
Q2
$29.4M Buy
40,876
+37,664
+1,173% +$27.1M 0.53% 51
2023
Q1
$2.64M Buy
3,212
+2,312
+257% +$1.9M 0.05% 176
2022
Q4
$649K Sell
900
-723
-45% -$522K 0.02% 334
2022
Q3
$1.12M Sell
1,623
-389
-19% -$268K 0.03% 240
2022
Q2
$1.19M Sell
2,012
-6,528
-76% -$3.86M 0.04% 210
2022
Q1
$5.97M Buy
8,540
+16
+0.2% +$11.2K 0.16% 94
2021
Q4
$5.38M Buy
8,524
+620
+8% +$392K 0.14% 120
2021
Q3
$4.78M Sell
7,904
-2,783
-26% -$1.68M 0.14% 115
2021
Q2
$6.14M Buy
10,687
+1,774
+20% +$1.02M 0.17% 93
2021
Q1
$4.22M Buy
8,913
+8,841
+12,279% +$4.18M 0.13% 113
2020
Q4
$35K Sell
72
-4,003
-98% -$1.95M ﹤0.01% 395
2020
Q3
$2.28M Sell
4,075
-2,511
-38% -$1.41M 0.1% 132
2020
Q2
$4.11M Buy
6,586
+2,335
+55% +$1.46M 0.26% 77
2020
Q1
$2.08M Buy
4,251
+4,111
+2,936% +$2.01M 0.14% 119
2019
Q4
$53K Sell
140
-98
-41% -$37.1K ﹤0.01% 460
2019
Q3
$66K Buy
238
+173
+266% +$48K ﹤0.01% 397
2019
Q2
$20K Sell
65
-173
-73% -$53.2K ﹤0.01% 456
2019
Q1
$98K Sell
238
-78
-25% -$32.1K 0.01% 242
2018
Q4
$118K Buy
+316
New +$118K 0.02% 223